In outpatients with COVID-19 during Omicron variant circulation, molnupiravir and nirmatrelvir-ritonavir improved outcomes. Chagla Z. Ann Intern Med 2024 Jan 2. doi: 10.7326/J23-0108.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chagla Z. In outpatients with COVID-19 during Omicron variant circulation, molnupiravir and nirmatrelvir-ritonavir improved outcomes. Ann Intern Med 2024 Jan 2. doi: 10.7326/J23-0108.
PMID: 38163374